Physician profile
William Ricci
NPI 1881612422
$11,602,219.15
in general payments reported to CMS, 2019-2025
7 companies · $2.2M in 2025
The $2.2M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.2M · 2020: $1.4M · 2021: $1.6M · 2022: $1.6M · 2023: $1.7M · 2024: $2.0M · 2025: $2.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.9M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $11K · Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,863,024.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,500.00 |
| Travel and Lodging | $10,717.51 |
| Food and Beverage | $1,730.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,412,909.71 | 2019-2025 | Evos, Evos Mini, Trigen |
| Microport Orthopedics INC | $187,460.11 | 2019-2021 | |
| Arthrex, INC. | $1,250.93 | 2019 | |
| Synthes Gmbh | $250.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $122.84 | 2021 | |
| Stryker Corporation | $118.14 | 2022 | |
| Depuy Synthes Sales INC. | $107.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ricci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.